OLA Blog

CKD AND BUSINESS DONT MIX!

Written by Meguid El Nahas on Wednesday, 26 August 2015. Posted in OLA Blog

CKD AND BUSINESS DONT MIX!
CKD DEFINITION, CLASSIFICATION AND EPIDEMIOLOGY; IS IT ALL ABOUT MONEY...?! In the US, labelling older people as suffering from CKD 3a (age related decline in kidney function) leads under the Medicare Advantage plans to enhanced reimbursements to...

UK BIOBANK AND MORTALITY PREDICTION: ONLY ASK...

Written by Meguid El Nahas on Sunday, 09 August 2015. Posted in OLA Blog

UK BIOBANK AND MORTALITY PREDICTION: ONLY ASK...
Lancet. 2015 Jun 2. pii: S0140-6736(15)60175-1. doi: 10.1016/S0140-6736(15)60175-1. [Epub ahead of print] 5 year mortality predictors in 498 103 UK Biobank participants: a prospective population-based study....

Therapeutic hypothermia for delayed graft function?

Written by arif khwaja on Friday, 31 July 2015. Posted in OLA Blog

Therapeutic hypothermia for delayed graft function?
Despite the plethora of publications regarding kidney transplantation outcomes, immunosuppression  remains remarkable similar in most centres. CNIs (usually tacrolimus), anti-metabolites (usually) MMF and steroids with IL2-receptor antagonism...

AVOID HF or not?

Written by Meguid El Nahas on Monday, 27 July 2015. Posted in OLA Blog

AVOID HF or not?
THE WINNING RAMADAN BLOG BY Dr MOHAMED ESSAM:   AVOID HF(1), a study designed to compare Aquapheresis (ultrafiltration) to IV diuretics with FU 90 days of discharge from the hospital to determine which patients had fewer Heart...

NEPHROLOGY PUBLICATIONS: FROM WORSE TO WORST!

Written by Meguid El Nahas on Wednesday, 08 July 2015. Posted in OLA Blog

NEPHROLOGY PUBLICATIONS: FROM WORSE TO WORST!
BLOG PROF ARIF KHWAJA (GLOBAL KIDNEY ACADEMY)   Clin J Am Soc Nephrol. 2015 Apr 21. pii: CJN.07370714. [Epub ahead of print] Rate of Change in Renal Function and Mortality in Elderly Treated Hypertensive Patients. Chowdhury...

IN TYPE 2 DIABETES WHAT YOU SEE PROBABLY IS NOT WHAT YOU GET!

Written by Jose Mario Franco de Oliveira on Monday, 06 July 2015. Posted in OLA Blog

IN TYPE 2 DIABETES WHAT YOU SEE PROBABLY IS NOT WHAT YOU GET!
Prof. Edwin A M Gale, recently has made a sound statement that we really Do Not know what really is type 2 diabetes mellitus, in a view-point piece he presented in Lancet: "Is Type 2 Diabetes  A  Categorical Error?" where he even...

Regenerating kidneys - are RAS blockers the answer?

Written by arif khwaja on Friday, 03 July 2015. Posted in OLA Blog

Regenerating kidneys - are RAS blockers the answer?
There is an interesting publication in JASN online by Remuzzi’s group looking at the effect of angiotensin II inhibition on glomerular vasculature. They use micro-CT and scanning EM to study the effect of RAS inhibition in Munich Wistar...

ROX or RISK?!

Written by Meguid El Nahas on Tuesday, 30 June 2015. Posted in OLA Blog

ROX or RISK?!
Lancet. 2015 Apr 25;385(9978):1634-41. doi: 10.1016/S0140-6736(14)62053-5. Epub 2015 Jan 23. Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled...

THE GLASSOCK BLOG: CKD EPIDEMIC...WHAT EPIDEMIC?

Written by Meguid El Nahas on Tuesday, 09 June 2015. Posted in OLA Blog

THE GLASSOCK BLOG: CKD EPIDEMIC...WHAT EPIDEMIC?
Is There a Real Global Epidemic of Chronic Kidney Disease? Numerous publications have asserted that the global prevalence of chronic kidney disease (CKD) in adults is generally between 10-13% (as determined from the KDOQI or KDIGO...

CKD "Epidemic": Wishful or Shameful Thinking?

Written by Meguid El Nahas on Monday, 08 June 2015. Posted in OLA Blog

CKD "Epidemic": Wishful or Shameful Thinking?
Prof Richard Glassock wrote in reference to the latest publication in the Lancet on the Global Burden of Disease Study 2013: (The Lancet On line 8th of June 2015) It represents massive data collection and a complicated analysis but the main...